SCHEMBL2796676

SCHEMBL2796676

O=C(O)C1CSSC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23829855 0.81
SCHEMBL4766425 0.80
Ammonia Solution, Strong SCHEMBL14645568 0.78
SCHEMBL1868130 0.75
SCHEMBL3012472 0.71
SCHEMBL28604726 0.69 CYP2C19 (0.39)
SCHEMBL8204743 0.67 CYP2C19 (0.50)
SCHEMBL375124 0.67 CYP2C19 (0.50)
Cyclopropane Carboxylic Acid SCHEMBL5499291 0.67
Cyclopropane Carboxylic Acid SCHEMBL4643 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260060402-A1 REMOVABLE NAIL COATINGS AND COMPOSITIONS AND METHODS OF PREPARING THEREOF LIQWD INC (US) 2026-03-05 US claimed
US-20260034043-A1 NAIL COMPOSITIONS INCLUDING SULFUR-CONTAINING AGENTS AND USES THEREOF LIQWD INC (US) 2026-02-05 US claimed
US-20250228996-A1 VASCULAR EMBOLIC AGENT, METHOD FOR PREPARING SAME AND USE THEREOF THE FIFTH AFFILIATED HOSPITAL SUN YAT-SEN UNIVERSITY (CN) 2025-07-17 US claimed
CN-116807947-B Anti-aging skin conditioner and application thereof 云南贝泰妮生物科技集团股份有限公司 2025-05-13 CN claimed
CN-119613360-A Cyclodiselenide/disulfide/carbon-bridged paclitaxel prodrug, and preparation and application of self-assembled nanoparticle thereof 沈阳药科大学 2025-03-14 CN claimed
EP-4410321-A1 VASCULAR EMBOLIC AGENT, METHOD FOR PREPARING SAME AND USE THEREOF The Fifth Affiliated Hospital Sun Yat-Sen University (CN) 2024-08-07 EP claimed
CN-114874414-B Asparagus resin and synthesis method thereof 深圳飞扬骏研新材料股份有限公司 2024-02-27 CN claimed
US-20230310461-A1 Compositions and Methods for Treatment of Prediabetes CROSS III WILLIAM H (US) 2023-10-05 US claimed
US-20230225952-A1 ADDITIVES FOR COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2023-07-20 US claimed
US-11353469-B2 Nontoxic compounds for use as taggants in nutritional and pharmaceutical products HALL LABS LLC (US) 2022-06-07 US claimed
CN-112040926-A Covalent treatment of keratin-containing materials with thiols 生活实验公司 2020-12-04 CN claimed
US-10657271-B2 Verification techniques for enhanced security INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2020-05-19 US claimed
WO-2019164841-A1 COVALENT TREATMENT WITH THIOLS OF KERATIN-CONTAINING MATERIALS LIVING PROOF, INC. (US) 2019-08-29 WO claimed
EP-2854888-B1 LIPOIC ACID COMPOSITIONS USEFUL AS ANTIMICROBIAL AGENTS BAYLOR COLLEGE MEDICINE (US) 2019-07-10 EP claimed
US-9956319-B2 Compositions useful as antibiofilm or antimicrobial agents and methods using same BAYLOR COLLEGE OF MEDICINE (US) 2018-05-01 US claimed
US-20170312329-A1 Compositions and Methods for Treatment of Prediabetes CROSS III WILLIAM H (US) 2017-11-02 US claimed
US-20170209413-A1 USE OF ASPARAGUSIC ACID AND DERIVATIVES THEREOF TO TREAT SYMPTOMS AND DISORDERS OF NEUROLOGICAL DISEASE WREEN JOSEPH (US) 2017-07-27 US claimed
US-20160328568-A1 VERIFICATION TECHNIQUES FOR ENHANCED SECURITY INTERNATIONAL BUSINESS MACHINES CORPORATION 2016-11-10 US claimed
US-20160330211-A1 VERIFICATION TECHNIQUES FOR ENHANCED SECURITY INTERNATIONAL BUSINESS MACHINES CORPORATION 2016-11-10 US claimed
US-20100209375-A1 PROCESS FOR TREATING KERATIN FIBERS WITH AT LEAST ONE HETEROCYCLIC DISULFIDE ENTITY IN THE PRESENCE OF AT LEAST ONE REDUCING AGENT, OPTIONALLY HEAT, AND OPTIONALLY AT ALKALINE PH. L'OREAL S.A. (FR) 2010-08-19 US claimed